Accomplishments of Bernardo Chua

Bernardo Chua is one of the most significant individuals in the field of entrepreneurship and has profoundly contributed to the rise and growth of a vast number of enterprise all over the world. Bernardo Chua began from humble backgrounds before rising into a very prestigious entrepreneur.

He started his career at Gano excel where he helped to manage the firm and develop strategies that would later see the company rise into an international one. The company launched some other branches in Canada, United States, and Hong Kong. Read more: Bernardo Chua: Founder And CEO Of Organo Gold

After serving various roles in the enterprise, Chua started his venture through which he helps people market their businesses and products.

Bernardo Chua makes his venture useful through the vast video coaching sessions that he conducts to equip his clients with the vast knowledge to make their business operations more efficient to attract a significant number of customers.

Chua later launched the Organo Gold company that focuses on offering its clients with the best tea and coffee products with the old Ganoderma, a Chinese herb. Through his vast experience gained in the previous firms that he served, Chua has developed particular business operation strategies to acquire a competitive advantage in the market. Learn more about Bernado Chua: http://www.zoominfo.com/p/Bernardo-Chua/676218748 and https://twitter.com/ogbernie

The successful entrepreneur employed direct selling of his products to his broad range of customers and believes that taking out his products directly to customers creates a lot of awareness among people concerning the product, hence increasing the number of individuals willing to buy it.

Due to the great success of Chua`s business strategies, his firm rose to a prestigious one and as a result acted as a source of employment for a significant number of individuals seeking employment.

Chua`s significant commitment towards achieving his goals has seen his company develop into a multimillion venture and he has been highly amended for his expertise.

Besides, Chua has won a series of awards due to his excellent contributions to the field of business. He has received an award for the best sales executive of the year as well as people’s choice award for the best coffee firm provides, among many other awards.

Chua looks forward towards employing better strategies to raise the standards of his company and expand it in many other countries.

Jim Tananbaum improves lives by harnessing healthcare’s future.

Jim Tananbaum is the CEO of Foresite Capital, a company he founded in 2011 as a private equity firm dedicated to identifying and nurturing emerging healthcare leaders. He has experience in the healthcare industry spanning for over 25 years as an investment strategist and healthcare entrepreneur. According to Mr. Tananbaum, Foresite Capital harnesses the future of healthcare. You can visit Ideamensch for more info.

Before founding Foresite, Jim Tananbaum had co-founded two leading biopharmaceutical companies; GelTex and Theravance, Inc. GelTex Pharmaceuticals brought to the market two new drugs at a cost less than $80 million. It was acquired later acquired at $1.6 billion. Today the market capitalization of the two companies is about $3.2 billion.

Jim Tananbaum has been on Forbes magazine’s Midas List for three consecutive years. The consistency is mainly due to his high investment in the healthcare industry. His early investment experience was a partner at Sierra Ventures then later as a founding partner of Prospect Venture II and III. The major investments which Mr. Tananbaum has led include Amira Pharmaceuticals, Healtheon, Jazz Pharmaceuticals and Amerigroup among others.

Jim Tananbaum founded Foresite Capital with the aim of creating a platform that brings together all the disciplines of his career. Intarcia is currently the company’s largest investment. It is a type II diabetes implant that controlling diabetes and weight gain. Jim believes that Intarcia has the potential to immensely control diabetes. If launched, it will improve the lives of millions of people since over 350 million people are either diabetic or obese globally.

Also, Foresite has invested in Aeri Pharmaceuticals to develop glaucoma treatment. Glaucoma is a principal cause of blindness and affects over 40 million people globally. It has also sponsored numerous other healthcare investments in synthetic biology, gene sequencing, data science and healthcare delivery.

Jim Tananbaum obtained a bachelor’s of science degree in mathematics and electrical engineering from Yale University before graduating with a master’s of science from MIT in 1989. He also holds a Doctor of Medicine (M.D) and MBA from Harvard Medical School and Harvard Business school respectively. His strategy is to focus on the next trend in healthcare and develop expertise for it. Checkout Forbes to know more.

Check out the website officialjimtananbaum.com

Source: http://www.fiercebiotech.com/venture-capital/foresite-capital-reloads-a-450m-biotech-venture-fund